Business Context and Reporting Period
This filing is a Form 13F-HR submitted by Takeda Pharmaceutical Co Ltd, an institutional investment manager. The report covers the quarter ended September 30, 2025, and was signed on November 13, 2025, by Max Heuer, the Authorized Signatory. The filing includes holdings for Takeda Pharmaceutical Co Ltd and one other included manager, Takeda Vaccines, Inc.
Key Financial Metrics
As a Form 13F filing, this document reports equity holdings rather than the operating financial performance of the reporting manager. The following metrics are disclosed:
- Total Value of Reported Holdings: $16,369,175
- Total Number of Holdings Entries: 9
- Number of Other Included Managers: 1 (Takeda Vaccines, Inc.)
Note: Revenue, profit, cash flow, margins, debt, and liquidity metrics for Takeda Pharmaceutical Co Ltd are not provided in this filing, as Form 13F is designed to disclose investment positions, not corporate financial statements.
Material Changes
The filing text does not provide comparative data for the prior period (e.g., June 30, 2025) to determine material changes in holdings or total value. The document is a standalone report for the quarter ended September 30, 2025.
Guidance, Outlook, and Risks
This filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is a regulatory disclosure of securities held at the end of the reporting period. The filing includes a standard disclaimer that the SEC has not reviewed the information for accuracy or completeness.
Investor Verification Checklist
- Verify the specific securities comprising the 9 holdings entries to understand the portfolio composition.
- Confirm the relationship between Takeda Pharmaceutical Co Ltd and the included manager, Takeda Vaccines, Inc.
- Compare the total reported value ($16,369,175) against prior quarter filings to assess portfolio growth or reduction.
- Review the full schedule of holdings (not included in this summary text) for individual position sizes and voting rights.